Furthermore, higher baseline NfL correlated with worse longitudinal clinical measures and brain atrophy in all FTD genetic mutation types, arguing that blood-based NfL is predictive of short-term risk for FTD disease progression.3,4,73,74. The gene discussed is NEFL; the disease is frontotemporal dementia.